BioCentury
ARTICLE | Clinical News

Cyclacel preclinical data

January 11, 2010 8:00 AM UTC

In 52 cell lines of NSCLC origin, 12 of the 13 cell lines which displayed the highest sensitivity to seliciclib in vitro contained Ras-activating mutations, while 0 of the 15 cell lines displaying the...